Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD

    Mar 12, 2025, 08:34 AM by
    Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD
    Full story
  • New Healthcare Security Benchmark Highlights Key Investment Priorities and Risks

    Mar 12, 2025, 01:00 AM by User Not Found
    Bio-IT World| At a session in the Cybersecurity Pavilion of ViVE last month, Cormac Miller, President and CCO of Censinet, presented the company’s 2025 cybersecurity benchmark for the healthcare sector. This year’s benchmark revealed that for the third year in a row, organizations are focusing on respond and recover capabilities.
    Full story
  • Syngene Acquires its First Manufacturing Facility in the US

    Mar 11, 2025, 08:12 AM by
    Full story
  • Venture Capital Needed to Fill Gaps Left by Uncertain Government Funding

    Mar 11, 2025, 01:00 AM by User Not Found
    Bio-IT World| Altitude Lab, the nonprofit formed by clinical-stage biotech company Recursion, recently launched a pre-seed venture fund to help 10 to 15 early-stage startups get through the current “period of uncertainty” around government funding—and other private investment groups will ideally follow suit over the short term.
    Full story
  • Genome Canada and Oxford Nanopore Technologies team up to advance genomics research in Canada

    Mar 6, 2025, 08:08 AM by
    Genome Canada and Oxford Nanopore Technologies announced a collaboration aimed at significantly enhancing genomics research across Canada.
    Full story
  • Pan-European Genomic Reanalysis Effort Yields Over 500 Diagnoses

    Mar 6, 2025, 01:00 AM by User Not Found
    Bio-IT World| A groundbreaking collaborative effort spanning 12 European countries and Canada has successfully identified genetic causes for more than 500 previously unsolved rare disease cases. Led by the University of Tübingen in Germany, the Solve-RD (Solving the Unsolved Rare Diseases) consortium brought together 300 experts from 37 institutions to leverage advanced genomic reanalysis techniques, ultimately providing long-awaited answers to patients and their families.
    Full story
  • Announcing BixBench: A Benchmark to Evaluate AI Agents on Bioinformatics Tasks

    Mar 5, 2025, 08:14 AM by
    Today, in partnership with ScienceMachine, FutureHouse is introducing BixBench, a benchmark designed to evaluate AI agents on real-world bioinformatics tasks. BixBench challenges AI models with open-ended analytical research scenarios, requiring them to analyze data, generate insights, and interpret results autonomously.
    Full story
  • Mural Health and ICON Announce Partnership to Enhance Participant and Site Experience in Clinical Trials

    Mar 5, 2025, 08:14 AM by
    Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.
    Full story
  • High-Performance Computing in the AI Era: Challenges and Future Prospects

    Mar 5, 2025, 01:00 AM by User Not Found
    Bio-IT World| In an era where artificial intelligence (AI) dominates discussions in technology, high-performance computing (HPC) remains the backbone of scientific discovery and enterprise research. Despite its critical role, HPC often operates in the background, much like electricity—only noticed when it fails. On the latest Trends from the Trenches Podcast, Dirk Petersen, Director of the Supercomputing Center at Oregon State University, shared his insights on the evolving role of HPC and its integration into AI-driven research.
    Full story
  • AI to Democratize Access to Cheap, High-Throughput Cardiotoxicity Testing

    Mar 4, 2025, 01:00 AM by User Not Found
    Bio-IT World| Researchers have trained an artificial intelligence (AI) model to reconstruct the electrical signals inside of heart cells based on recordings taken from outside those cells, opening the possibility of cheap, high-yielding cardiotoxicity testing using commercially available microelectrode arrays. The hope is that the U.S. Food and Drug Administration (FDA) will allow the tool to be used in lieu of inserting pipettes into cells to record signaling changes with the addition of a drug, which is both costly and cumbersome to do at scale.
    Full story
  • Owkin Launches ATLANTIS: An Extensive Multimodal Patient Data Discovery Program Across 7 Countries in 11 Therapeutic Areas

    Feb 28, 2025, 08:10 AM by
    Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.
    Full story
  • The False Dichotomy of Short Reads vs. Long Reads

    Feb 28, 2025, 01:00 AM by User Not Found
    Bio-IT World| The rate of evolution of DNA sequencing technologies since the introduction of the Sanger method in the 1970s has been astounding. It’s just over 20 years since the publication of the first draft human genome and today, technologies can deliver that same information for as little as $100.
    Full story
  • eClinical Solutions Details Strong 2024 and Announces New Products Aimed at Reducing Cycle Times for Biopharma

    Feb 27, 2025, 10:28 AM by
    Company prioritizes efficiency through innovation with new embedded AI and automation platform capabilities, including a GenAI-Powered Chatbot and Clean Progress Tracking
    Full story
  • Biocair Announces Further Expansion in the APAC Region As Part of Global Growth Strategy

    Feb 27, 2025, 10:28 AM by
    Biocair, an established global leader in life science logistics, announces the expansion of its operations with the opening of a new office in Chengdu, Sichuan Province, China.
    Full story
  • RNA in Oncology Research, Ultima Genomics Commercially Launches Platform, More

    Feb 27, 2025, 09:20 AM by User Not Found
    Bio-IT World| InfoBionic.Ai’s MoMe ARC delivers real-time cardiac insights, empowering physicians to improve patient outcomes; Ultima Genomics announced the commercial launch of UG 100 Solaris; and more.
    Full story
  • Follow the Money: 3D Spatial Biology, AI-Powered Imaging Biomarkers, More

    Feb 26, 2025, 08:13 AM by User Not Found
    Bio-IT World| Stellaromics commercializes their 3D spatial biology platform, Pyxa; Latent Labs’ AI platform shows promising potential to open new paths to personalized medicines; and more.
    Full story
  • Oxford Nanopore expands compatibility with 10x Genomics to unlock deeper insights in single-cell transcriptomics

    Feb 25, 2025, 08:07 AM by
    Oxford Nanopore has expanded its collaboration with 10x Genomics to help improve single-cell transcriptomics research.
    Full story
  • Sphere Fluidics rebrands to Sphere Bio

    Feb 25, 2025, 08:07 AM by
    Sphere Fluidics today announced its rebranding to Sphere Bio. The name change marks a significant milestone in the Company’s development, reflecting its transition from a leading droplet-based microfluidics innovator to an established commercial provider of integrated life sciences tools and solutions.
    Full story
  • Vector Laboratories Announces the Appointment of Ashley Scholz as Vice President of Marketing

    Feb 25, 2025, 08:07 AM by
    Vector Laboratories has appointed Ashley Scholz as its new Vice President of Marketing. Ashley brings 16+ years of experience in medical devices, cancer diagnostics, and molecular diagnostics, most recently leading marketing at W.L. Gore & Associates.
    Full story
  • Qureight core imaging platform deployed within Vicore Phase 2b ASPIRE study of buloxibutid for IPF

    Feb 24, 2025, 08:06 AM by
    Qureight Ltd and Vicore Pharma today announce the implementation of Qureight’s Core Imaging Platform within the global Phase 2b ASPIRE trial investigating buloxibutid in patients with idiopathic pulmonary fibrosis (IPF).
    Full story
  • «
  • 11
  • 12
  • 13
  • 14 (current)
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy